Fig. 1. Flow chart of study selection for efficacy and BTcP characteristics of Korean patients. BTcP, breakthrough cancer pain

Korean J Clin Pharm 2023;33:43-50 https://doi.org/10.24304/kjcp.2023.33.1.43

© 2023 Korean J Clin Pharm